ENA-78/CXCL5 and GRO-α/CXCL1 have been shown to have increased expression in tumors of patients with malignant versus non-malignant pancreas tumors, suggesting a role for these genes in pancreatic carcinogenesis. This evidence concerns the gene CXCL5 and pancreatic neoplasm.